Navigation Links
Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs
Date:8/31/2009

r-stage trials in a number of indications."

Dr. Chabner has contributed to important advances in cancer drug research and clinical trial design during a distinguished career that spans four decades. Dr. Chabner is a member of the National Cancer Advisory Board and is editor-in-chief of the journal The Oncologist. He graduated with honors from Yale College and received his M.D. degree from Harvard Medical School.

"The increased attention bavituximab and Cotara have been receiving from oncology researchers is exemplified by the fact that Dr. Chabner, globally recognized as a leading cancer researcher and key opinion leader, has chosen to become actively involved in helping to guide our clinical programs," said Steven W. King, president and CEO of Peregrine. "We believe Dr. Chabner's contributions will be very valuable as we design the next set of bavituximab clinical studies that are critical to advance the program through later-stage clinical trials."

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceut
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
2. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
3. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
4. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
5. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
6. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
7. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
10. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
11. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... annual revenues in the past three years. Today, the business ... , According to the sales manager of the company, this ... in 2015. This point can be reflected on the discounted ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Blood-lead Tests to Pregnant Women and Young Children , ... today reminded Pennsylvania parents to test young children for ... Week, Oct. 18-24. , "Parents and caregivers need ... tested for lead poisoning," said Secretary of Health Everette ...
... Contrary to what was previously assumed, overweight is not increasing ... of the Faculty of Mathematics, Computer Science, and Natural Sciences ... and other results in the current issue of Deutsches ... 641𔃆)., Most Germans are overweight, with a body mass index ...
... (HAART) to treat HIV-1 infection are less likely than ... through breastfeeding, according to a new study. The findings, ... The Journal of Infectious Diseases , suggest HAART ... eligible mothers in areas with limited resources, such as ...
... ... keeps students informed to combat flu , ... Victoria, BC (PRWEB) October 16, 2009 -- While most Canadians ... still a very real health concern. That’s why University Canada West is keeping its ...
... cost for sugary drinks haven,t slowed obesity epidemic, study finds ... taxes and levies on soft drinks are slowing consumption, but ... States, researchers say. , In an analysis of 16 years ... soft drink taxation affected body mass index, researchers found that ...
... Medifast, Inc. (NYSE: MED ), a provider of leading ... one of "America,s 200 Best Small Companies" by Forbes magazine. ... has recognized Medifast, advancing to number 16 on the list ... the article Forbes states, "Our list of the 200 Best ...
Cached Medicine News:Health News:Pennsylvania Observes National Lead Poisoning Prevention Week 2Health News:Maternal HIV-1 treatment protects against transmission to newborns 2Health News:Schools Still on Alert for H1N1 Outbreaks 2Health News:Soda Taxes Not Making a Dent in U.S. Waistlines 2Health News:Medifast, Inc. Named by Forbes as One of 'America's 200 Best Small Companies' 2Health News:Medifast, Inc. Named by Forbes as One of 'America's 200 Best Small Companies' 3
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the number of ... compound, LB‑100, is being conducted, has been expanded from 1 ... M.D., the founder and President of Lixte, said that, "the ... site. Accrual of patients, however, was slower than projected. The ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... WASHINGTON, June 15, 2011 A new ad campaign launched ... country have in finding savings for their state,s Medicaid program: ... drugstores. States and the federal government could save $33 ... overpayments and modernizing pharmacy benefits to be more like those ...
... 2011 MedNet Solutions, a global life sciences technology ... pleased to announce that MedNet will be showcasing its ... Drug Information Association (DIA) Annual Meeting in Chicago, IL ... the commercial release of iMedNet EDC earlier this year, ...
Cached Medicine Technology:The Medicaid Choice: Cut Benefits for Patients or Overpayments to Independent Drugstores 2MedNet Solutions to Showcase Its Complete Suite of eClinical Solutions at the 47th DIA Annual Meeting 2
... new highly sensitive and specific second-generation peptide-based ... on the detection of autoantibodies against the ... residues in human serum or plasma. Enabling ... Anti-CCP assay provides an additional tool in ...
Latex agglutination inhibition slide test for the qualitative detection of hCG in urine....
Color-enhanced slide test for the rapid qualitative and semi-quantitative detection of antibodies to streptococcal extracellular antigens in serum, plasma and peripheral blood....
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
Medicine Products: